Date published: 2026-3-31

1-800-457-3801

SCBT Portrait Logo
Seach Input

HDHD2 Activators

HDHD2, or Haloacid Dehalogenase-Like Hydrolase Domain Containing 2, is an enzyme encoded by the HDHD2 gene in humans. It belongs to the haloacid dehalogenase (HAD) superfamily, which comprises a large group of hydrolases. These enzymes are characterized by their ability to catalyze the hydrolysis of a wide range of substrates, including phosphates, sulfates, and carboxylic acid esters.HDHD2 specifically exhibits phosphatase activity, functioning in the dephosphorylation of various substrates within the cell. This enzymatic action is crucial for regulating the phosphorylation status of proteins and other molecules, which is a key mechanism in controlling cellular processes such as signal transduction, metabolism, and cell growth.

The precise biological role of HDHD2 is not fully elucidated, but its phosphatase activity suggests its involvement in important cellular pathways. Phosphorylation and dephosphorylation are essential for the modulation of enzyme activities, the activation/inactivation of signaling pathways, and the regulation of cell cycle progression. Therefore, HDHD2 likely plays a role in these processes through its enzymatic function.Alterations in the expression or function of HDHD2 could have significant implications for cellular regulation and homeostasis. Abnormal HDHD2 activity may be linked to various pathologies, including metabolic disorders, signal transduction abnormalities, and potentially cancer, given the critical role of phosphatases in cell growth and proliferation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates adenylate cyclase, increasing cAMP levels, which could indirectly influence HDHD2 by modulating cellular signaling pathways.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX is a non-selective inhibitor of phosphodiesterase, leading to increased cAMP and cGMP levels in cells, potentially impacting HDHD2 activity.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram, a selective phosphodiesterase 4 inhibitor, increases cAMP levels, potentially affecting signaling pathways relevant to HDHD2.

Caffeine

58-08-2sc-202514
sc-202514A
sc-202514B
sc-202514C
sc-202514D
50 g
100 g
250 g
1 kg
5 kg
$33.00
$67.00
$97.00
$192.00
$775.00
13
(1)

Caffeine, a known phosphodiesterase inhibitor, can increase cAMP levels, possibly influencing HDHD2 activity indirectly.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin, with its broad biological activity, can modulate various cellular pathways, potentially intersecting with HDHD2's function.

Theophylline

58-55-9sc-202835
sc-202835A
sc-202835B
5 g
25 g
100 g
$20.00
$32.00
$85.00
6
(0)

Theophylline, another phosphodiesterase inhibitor, increases cAMP levels, potentially affecting pathways involving HDHD2.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG, a major component of green tea, has a wide range of biological effects, including modulation of signaling pathways that might interact with HDHD2.

Milrinone

78415-72-2sc-201193
sc-201193A
10 mg
50 mg
$165.00
$697.00
7
(0)

Milrinone, a phosphodiesterase 3 inhibitor, increases cAMP levels, which could have implications for HDHD2 activity.

Pentoxifylline

6493-05-6sc-203184
1 g
$20.00
3
(1)

Pentoxifylline, a phosphodiesterase inhibitor, elevates cAMP levels and could indirectly affect HDHD2's role in cellular signaling.

Vinpocetine

42971-09-5sc-201204
sc-201204A
sc-201204B
20 mg
100 mg
15 g
$55.00
$214.00
$2400.00
4
(1)

Vinpocetine, a phosphodiesterase 1 inhibitor, increases cAMP and cGMP levels, potentially impacting HDHD2 activity.